||CsnPharm

欢迎来到CSNpharm！产品仅用于科研！

400-920-2911 sales@csnpharm.cn

^NEW 新产品

登录 | 注册会员中心 0

您的位置 : 首页 / Anti-infection / GSK2838232

CAS No.: 1443460-91-0

GSK2838232 Catalog No. CSN17865

GSK2838232 inhibit HIV reverse transcriptase activity across a broad panel of HIV-1 isolates,

规格	价格	促销价格	库存	数量

400-920-2911

sales@csnpharm.cn

tech@csnpharm.cn

加入购物车大规格询价

产品咨询

400-920-2911

sales@csnpharm.cn

tech@csnpharm.cn

纯度 & 质量文件批次:

靶点选择性

生物活性

描述GSK2838232 inhibit HIV reverse transcriptase activity across a broad panel of HIV-1 isolates,
临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
NCT01802918	Infection, Human Immunodeficie... more >>ncy Virus Collapse <<	Phase 1	Completed	-	United States, Maryland ... more >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Collapse <<
NCT03234036	Infection, Human Immunodeficie... more >>ncy Virus Collapse <<	Phase 1	Completed	-	United States, Maryland ... more >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Collapse <<
NCT02289482	Infection, Human Immunodeficie... more >>ncy Virus Collapse <<	Phase 1	Terminated(Study prematurely t... more >>erminated due to safety concerns leading to clinical hold) Collapse <<	-	United States, Maryland ... more >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Collapse <<

更多

实验方案

计算器摩尔计算器总药量计算器工作液计算器
储存液制备
- 1 mg
- 5 mg
- 10 mg
- 1 mM
- 1.2352 mL
- 6.1762 mL
- 12.3524 mL
- 5 mM
- 0.2470 mL
- 1.2352 mL
- 2.4705 mL
- 10 mM
- 0.1235 mL
- 0.6176 mL
- 1.2352 mL

技术信息

CAS号	1443460-91-0		储存条件	粉末液体 -20°C:3-6 月 -80°C:12月
分子式	C48H73ClN2O6		运输	蓝冰
分子量	809.56		别名

大规格询价

号为必填项

姓名: 邮箱: 手机号:

留言:

提交

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT01802918	Infection, Human Immunodeficie... more >>ncy Virus Collapse <<	Phase 1	Completed	-	United States, Maryland ... more >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Collapse <<
NCT03234036	Infection, Human Immunodeficie... more >>ncy Virus Collapse <<	Phase 1	Completed	-	United States, Maryland ... more >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Collapse <<
NCT02289482	Infection, Human Immunodeficie... more >>ncy Virus Collapse <<	Phase 1	Terminated(Study prematurely t... more >>erminated due to safety concerns leading to clinical hold) Collapse <<	-	United States, Maryland ... more >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Collapse <<
NCT02289495	Infection, Human Immunodeficie... more >>ncy Virus Collapse <<	Phase 1	Terminated	-	United States, Maryland ... more >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Collapse <<
NCT02795754	Infection, Human Immunodeficie... more >>ncy Virus Collapse <<	Phase 1	Completed	-	United States, Maryland ... more >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Collapse <<
NCT03045861	Infection, Human Immunodeficie... more >>ncy Virus Collapse <<	Phase 2	Completed	-	United States, Alabama ... more >> GSK Investigational Site Birmingham, Alabama, United States, 35226 United States, California GSK Investigational Site Bakersfield, California, United States, 93301 GSK Investigational Site Long Beach, California, United States, 90813 GSK Investigational Site Los Angeles, California, United States, 90027 GSK Investigational Site Los Angeles, California, United States, 90069 GSK Investigational Site San Francisco, California, United States, 94109 United States, District of Columbia GSK Investigational Site Washington, District of Columbia, United States, 20009 United States, Florida GSK Investigational Site Fort Lauderdale, Florida, United States, 33316 GSK Investigational Site Fort Pierce, Florida, United States, 34982 GSK Investigational Site Miami, Florida, United States, 33133 GSK Investigational Site Orlando, Florida, United States, 32803 GSK Investigational Site Pensacola, Florida, United States, 32503 GSK Investigational Site West Palm Beach, Florida, United States, 33401 United States, Georgia GSK Investigational Site Macon, Georgia, United States, 31201 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60613 United States, Massachusetts GSK Investigational Site Springfield, Massachusetts, United States, 01107 United States, Michigan GSK Investigational Site Berkley, Michigan, United States, 48072 United States, New Jersey GSK Investigational Site Newark, New Jersey, United States, 07102 United States, Texas GSK Investigational Site Bellaire, Texas, United States, 77401 GSK Investigational Site Dallas, Texas, United States, 75246 GSK Investigational Site Longview, Texas, United States, 75602 Canada, Ontario GSK Investigational Site Ottawa, Ontario, Canada, K1H 8L6 GSK Investigational Site Toronto, Ontario, Canada, M5G 2C4 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2L 4P9 Collapse <<

总药量计算器 ✕

动物实验：给药剂量mg/kg 动物体重g 动物数量只每天给药次给药天

需要的总药量：mg

工作液计算器 ✕

动物实验：给药剂量mg/kg 动物体重g 给药体积μL

您需要配制的工作液浓度为：mg/mL

优势价格
快速发货
品质保证
技术支持

联系我们

sales@csnpharm.cn

官方电话：400-920-2911
二维码
微信公众号 CSN官网

dandb BBB norton fedex dhl ups 顺丰沪公网安备 31011002004927号，沪ICP备09052192号-6 危化品许可证:沪(杨)应急管危经许[2021]203479(QYS)

csnpharm版权所有2023，产品仅用于科研！